Scott+Scott, Attorneys at Law, LLP Announces Investigation into MiMedx Group Inc. (MDXG)

NEW YORK, Feb. 22, 2018 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating into whether MiMedx Group Inc.  ("MiMedx" or the "Company") (NASDAQ: MDXG) or its officers and directors violated federal securities laws.  If you purchased MiMedx securities, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.

MiMedx is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone.

On February 20, 2018, pre-market, MiMedx announced that it was postponing the release of its fourth quarter and fiscal year 2017 financial results.  The Company also announced that its Audit Committee is conducting "an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company."

On this news, the Company's stock fell 39.5% on February 20, 2018, from its previous close of $14.47 to $8.75.

What You Can Do

If you purchased MiMedx securities, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at (844) 818-6982, or at [email protected], or visit https://scott-scott.com/investigation/mimedx-group-inc/.

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

CONTACT:
Joe Pettigrew
Scott+Scott, Attorneys at Law, LLP
(844) 818-6982
[email protected] 

SOURCE Scott+Scott, Attorneys at Law, LLP